0001209191-16-130134.txt : 20160629 0001209191-16-130134.hdr.sgml : 20160629 20160629194553 ACCESSION NUMBER: 0001209191-16-130134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160627 FILED AS OF DATE: 20160629 DATE AS OF CHANGE: 20160629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krassner Stuart Mitchell CENTRAL INDEX KEY: 0001311636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 161740135 MAIL ADDRESS: STREET 1: 157 TEHCNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-27 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001311636 Krassner Stuart Mitchell 11500 S. EASTERN AVENUE SUITE 240 HENDERSON NV 89052 1 0 0 0 Common Stock, $0.001 par value 2016-06-27 4 F 0 880 6.47 D 40370 D Common Stock, $0.001 par value 2016-06-28 4 F 0 3523 6.33 D 36847 D Common Stock, $0.001 par value 2016-06-28 4 A 0 10000 0.00 A 46847 D Stock Option (Right to Buy) 6.33 2016-06-28 4 A 0 20000 6.33 A 2026-06-28 Common Stock 20000 20000 D Represents restricted shares withheld by Spectrum to satisfy Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent. 100% of the restricted shares shall vest on the earlier of (1) June 28, 2017 or (2) the date of the company's 2017 Annual Meeting of Shareholders. 25% of the option shares vested on June 28, 2016. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. /s/ Kurt A. Gustafson, attorney-in-fact for Stuart M. Krassner 2016-06-29